Despite challenges of decision making for unrepresented patients, few laws or policy statements offer solutions. This article offers 5 key things to do.
AMA J Ethics. 2019; 21(7):E582-586. doi:
10.1001/amajethics.2019.582.
Distinguishing between elective and therapeutic abortions undermines the moral agency of patients and disproportionately amplifies moral rather than medical dimensions of the procedure.
AMA J Ethics. 2018; 20(12):E1175-1180. doi:
10.1001/amajethics.2018.1175.
Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision.
AMA J Ethics. 2016; 18(4):359-364. doi:
10.1001/journalofethics.2016.18.4.ecas1-1604.
Labels commonly used in clinical settings, like “elective” or “therapeutic,” influence how we think about the justifiability of abortion. We talk with Professor Katie Watson and Dr Maryl Sackeim about how the language clinicians use to describe abortion can affect patients’ experiences and even cause harm.
Efrat Lelkes, MD, Angira Patel, MD, MPH, Anna Joong, MD, and Jeffrey G. Gossett, MD
Current policy requires separate informed consent for some Public Health Service increased-risk donors, and this can make shared decision making harder.
AMA J Ethics. 2020; 22(5):E401-407. doi:
10.1001/amajethics.2020.401.
Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity.
AMA J Ethics. 2020; 22(5):E358-364. doi:
10.1001/amajethics.2020.358.
Legacy patients are so-called because their opioid use behaviors express past, aggressive opioid prescribing by a clinician. Managing their pain and dependence justly is ethically complex.
AMA J Ethics. 2020; 22(8):E651-657. doi:
10.1001/amajethics.2020.651.